Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishment of a Reference Clinical Sample Panel Allowing for the Development and Proof-of-concept Validation of an In-vitro Diagnostic Test for the Diagnosis of Melioidosis

NCT02668406 is registered in ClinicalTrials.gov with Institute of Tropical Medicine, Belgium as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02668406 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishment of a Reference Clinical Sample Panel Allowing for the Development and Proof-of-concept Validation of an In-vitro Diagnostic Test for the Diagnosis of Melioidosis
Lead sponsor
Institute of Tropical Medicine, Belgium
Phase
Observational
Overall status
Completed
Start date
February 29, 2016
Completion date
September 30, 2018
Enrollment
4,203 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

melioidosis, suspected or confirmed bloodstream infections, systemic inflammatory response syndrome